Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-02-14
2010-06-22
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S549000, C514S552000
Reexamination Certificate
active
07741368
ABSTRACT:
Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. Various BPI inducing agents include icosapentanoic acid (EPA) analogs and docosahexaenoic acid (DHA) analogs.
REFERENCES:
patent: 4201211 (1980-05-01), Chandrasekaran et al.
patent: 4666701 (1987-05-01), Horrobin et al.
patent: 4810424 (1989-03-01), Gerwick et al.
patent: 5409955 (1995-04-01), Bockow et al.
patent: 5411988 (1995-05-01), Bockow et al.
patent: 5604258 (1997-02-01), Ferrante et al.
patent: 5650157 (1997-07-01), Bockow
patent: 5709855 (1998-01-01), Bockow et al.
patent: 5752238 (1998-05-01), Dedrick
patent: 5814599 (1998-09-01), Mitragotri et al.
patent: 5846974 (1998-12-01), Kallman et al.
patent: 5861399 (1999-01-01), Seed et al.
patent: 5912006 (1999-06-01), Bockow et al.
patent: 6030715 (2000-02-01), Thompson et al.
patent: 6069109 (2000-05-01), Kao et al.
patent: 6117911 (2000-09-01), Grainger et al.
patent: 6201022 (2001-03-01), Mease et al.
patent: 6232467 (2001-05-01), Petasis et al.
patent: 6259699 (2001-07-01), Opalka et al.
patent: 6272474 (2001-08-01), Garcia
patent: 6336105 (2002-01-01), Conklin et al.
patent: 6949664 (2005-09-01), Petasis
patent: 7030159 (2006-04-01), Serhan et al.
patent: 7053230 (2006-05-01), Serhan et al.
patent: 7341840 (2008-03-01), Serhan et al.
patent: 2002/0055539 (2002-05-01), Bockow et al.
patent: 2002/0111505 (2002-08-01), Serhan
patent: 2003/0236423 (2003-12-01), Petasis
patent: 2004/0044050 (2004-03-01), Goodman et al.
patent: 2005/0228047 (2005-10-01), Petasis
patent: 2006/0128804 (2006-06-01), Serhan et al.
patent: 2006/0293288 (2006-12-01), Serhan et al.
patent: 2008/0096961 (2008-04-01), Serhan et al.
patent: 2033745 (1980-05-01), None
patent: XP-002184773 (1990-07-01), None
patent: 5186342 (1993-07-01), None
patent: WO 91/16914 (1991-11-01), None
patent: WO 98/46588 (1998-10-01), None
patent: 9956727 (1999-11-01), None
patent: 9956727 (1999-11-01), None
patent: 0032210 (2000-06-01), None
patent: WO 00/74632 (2000-12-01), None
Testa “Prodrug research: futile or fertile?” Biochemical Pharmacology, 2004, vol. 68, pp. 2097-2106.
Slots, et al., “General Health Risk of Periodontal Disease”, International Dental Journal, Dec. 2001, 51(6), pp. 417-422.
Green, Gary A., “Understanding NSAIDS: From Aspirin to COX-2”, Clinical Cornerstone, Sports Medicine 2001, 3(5), pp. 50-59.
Merck Index, “Gingivitis”, Copyright © 1995-2007 Merck & Co., Inc., Whitehouse Station, NJ, USA, Last Full Version, Feb. 2003, 3 pgs.
Stella, Valentino J., “Expert Opinion of Therapeutic Patents”, Prodrugs as Therapeutics, 2004, 14(3), pp. 277-280.
Wolff et al., “Burger's Medicinal Chemistry and Drug Discovery”, 5thEd., vol. 1, pp. 975-977, 1994.
Dragoli et al., “Parallel Synthesis of Prostaglandin E1Analogues”, J. Comb. Chem., 1999, pp. 534-539.
J.W. Karanian et al., “Inhibitory Effects of n-6 and n-3 Hydroxy Fatty Acids on Thromboxane (U46619)-Induced Smooth Muscle Contraction”, The Journal of Pharmcology and Experimental Therapeutics, vol. 270, No. 3, pp. 1105-1109, 1994, XP-009087752.
Khalfoun, B., “Docosahexaenoic and Eicosapentaenoic Acid Inhibit Human Lymphoproliferative Responses In Vitro but not the Expression of T cell Surface Activation Markers”, Scand. J. of Immunol., vol. 43, pp. 248-256, 1996, XP-000878923.
Croset, M., et al., “Inhibition by Lipoxygenase Products of TXA2-Like Responses of Platelets and Vascular Smooth Muscle”, Biochemical Pharmacology, vol. 37, No. 7, pp. 1275-1280, 1988, XP-002445509.
“Epolinsatures”, Bulletin De La Societe Chimique de France, No. 3, pp. 419-432, 1989.
Khair-El-Din, et al. “Transcription of the Murine iNOS Gene is Inhibited by Docosahexaenoic Acid, a Major Constituent of Fetal and Neonatal Sera as Well as Fish Oils”,J. Exp. Med.,vol. 183, pp. 1241-1246, 1996.
Schmedtje, Jr. et al., “Hypoxia Induces Cyclooxygenase-2 via the NF- Kb p65 Transcription Factor in Human Vascular Endothelial Cells”,J. Biol. Chem.,vol. 272, No. 1, 1997, pp. 601-608.
Serhan et al., “Novel functional sets of lipid-derived mediators with Anti-inflammatory Actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellular processing”,J. Exp. Med.,vol., 192, No. 8, 2000, pp. 1197-1204.
Takeshi Terano et al., “Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex”,Biochem. Biophys. Res. Comm.,vol. 254, pp. 502-506.
Chemical Abstracts online citation, AN:2004:143088, retrieved Aug. 15, 2007, from STN, Columbus, OH.
Hong, et al. “Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docasahexaenoic acid-derived resolvins and protectins—mediator lipidomic analysis”,Prostaglandins&Other Lipid Mediators,Elsevier, vol. 78, No. 1-4, Jun. 13, 2005, pp. 107-116. XP005174168.
Serhan, Charles N. et al. “Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and it's Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes”, Journal of Immunology, 176(3), 1848-1959 Coden: J01MA3; ISSN 0022-1767, Feb. 1, 2006. XP002429095.
Levy, Bruce D. et al. “Protectin D1 is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness,”The Journal of Immunology,2007, 178: 496-502.
PCT/US2006/038326 International Search Report dated Apr. 23, 2007.
PCT/US2006/000306 International Search Report dated Jul. 14, 2006.
PCT/US2003/25336 International Search Report dated Feb. 16, 2004.
PCT/US2001/05196 International Search Report dated Jul. 19, 2002.
EP 06 02 2386 European Search Report dated Oct. 5, 2007.
PCT/US2005/12552 International Search Report dated Aug. 24, 2005 (in name of Trustees of Boston University).
PCT/US2006/011222 International Search Report dated Oct. 5, 2007.
PCT/US2005/009056 International Search Report dated Nov. 16, 2005.
Knapp, Howard R., et al., “Bactericidal Effects of Polyunsaturated Fatty Acids”, The Journal of Infectious Diseases, vol. 154,No. 1, 1986 pp. 84-94.
Cooper, S.F., et al., “Identification of Antibacterial Fatty Acids fromPhaeodactylum tricomtumgrown i dialysis culture”, The Faculty Press, 1985, pp. 28-36.
Karanian, J.W. et al., “Physiological functions of hydroxy-docosahexaenoic acid”, Abstract, XP-002200246, 1993.
Hill, E.M. et al., “Identification and egg hatching activity of monohydroxy fatty acid eicosanoids in the barnacleBalanus balanoides”, Abstract, XP-002200247, 1992.
Ganz, T. et al., “Antimicrobial peptides of phagocytes and epithelia”,Seminars in Hematology,vol. 34, No. 4, 1997, pp. 343-354.
Elsbach, P. et al., “Role of the bactericidal/permeability-increasing protein in host defence”,Current Opinion in lmmunlogy,vol. 10, No. 1, 1998, pp. 45-49.
Levy, O., “A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein”,Antimicrobial Agents and Chemotherapy,vol. 44, No. 11, 2000, pp. 2925-2931.
Levy, O., “Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents”,Blood,vol. 96, No. 8, 2000, pp. 2664-2672.
Beamer, L.J. et al., “Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution”,Science,vol. 276, 1997, pp. 1861-1864.
Lockhart, D.J. et al., “Expression monitoring by hybridization to high-density oligonucleotide arrays”,Nature Biotechnology,vol. 14, No. 13, 1996, pp. 1675-1680.
Serhan, C.N. et al., “Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory durgs and transcellular processing”,J. Exp. Med.,vol. 192, No. 8, 2000, pp. 1197-1204.
Serhan, C.N. et al., “R
Colgan Sean P.
Serhan Charles N.
Fairman Colin L.
Fulbright & Jaworski LLP
Rothenberger Scott D.
The Brigham and Women's Hospital, Inc.
Wang Shengjun
LandOfFree
Approach to antimicrobial host defense with molecular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Approach to antimicrobial host defense with molecular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Approach to antimicrobial host defense with molecular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4165824